{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "f156f64b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: sentence-transformers in /opt/anaconda3/lib/python3.12/site-packages (4.1.0)\n",
      "Requirement already satisfied: transformers<5.0.0,>=4.41.0 in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (4.52.4)\n",
      "Requirement already satisfied: tqdm in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (4.66.5)\n",
      "Requirement already satisfied: torch>=1.11.0 in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (2.7.1)\n",
      "Requirement already satisfied: scikit-learn in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (1.5.1)\n",
      "Requirement already satisfied: scipy in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (1.13.1)\n",
      "Requirement already satisfied: huggingface-hub>=0.20.0 in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (0.33.0)\n",
      "Requirement already satisfied: Pillow in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (10.4.0)\n",
      "Requirement already satisfied: typing_extensions>=4.5.0 in /opt/anaconda3/lib/python3.12/site-packages (from sentence-transformers) (4.14.0)\n",
      "Requirement already satisfied: filelock in /opt/anaconda3/lib/python3.12/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (3.13.1)\n",
      "Requirement already satisfied: fsspec>=2023.5.0 in /opt/anaconda3/lib/python3.12/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (2024.6.1)\n",
      "Requirement already satisfied: packaging>=20.9 in /opt/anaconda3/lib/python3.12/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (24.1)\n",
      "Requirement already satisfied: pyyaml>=5.1 in /opt/anaconda3/lib/python3.12/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (6.0.1)\n",
      "Requirement already satisfied: requests in /opt/anaconda3/lib/python3.12/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (2.32.3)\n",
      "Requirement already satisfied: hf-xet<2.0.0,>=1.1.2 in /opt/anaconda3/lib/python3.12/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (1.1.5)\n",
      "Requirement already satisfied: setuptools in /opt/anaconda3/lib/python3.12/site-packages (from torch>=1.11.0->sentence-transformers) (75.1.0)\n",
      "Requirement already satisfied: sympy>=1.13.3 in /opt/anaconda3/lib/python3.12/site-packages (from torch>=1.11.0->sentence-transformers) (1.14.0)\n",
      "Requirement already satisfied: networkx in /opt/anaconda3/lib/python3.12/site-packages (from torch>=1.11.0->sentence-transformers) (3.3)\n",
      "Requirement already satisfied: jinja2 in /opt/anaconda3/lib/python3.12/site-packages (from torch>=1.11.0->sentence-transformers) (3.1.4)\n",
      "Requirement already satisfied: numpy>=1.17 in /opt/anaconda3/lib/python3.12/site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (1.26.4)\n",
      "Requirement already satisfied: regex!=2019.12.17 in /opt/anaconda3/lib/python3.12/site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (2024.9.11)\n",
      "Requirement already satisfied: tokenizers<0.22,>=0.21 in /opt/anaconda3/lib/python3.12/site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (0.21.1)\n",
      "Requirement already satisfied: safetensors>=0.4.3 in /opt/anaconda3/lib/python3.12/site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (0.5.3)\n",
      "Requirement already satisfied: joblib>=1.2.0 in /opt/anaconda3/lib/python3.12/site-packages (from scikit-learn->sentence-transformers) (1.4.2)\n",
      "Requirement already satisfied: threadpoolctl>=3.1.0 in /opt/anaconda3/lib/python3.12/site-packages (from scikit-learn->sentence-transformers) (3.5.0)\n",
      "Requirement already satisfied: mpmath<1.4,>=1.1.0 in /opt/anaconda3/lib/python3.12/site-packages (from sympy>=1.13.3->torch>=1.11.0->sentence-transformers) (1.3.0)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in /opt/anaconda3/lib/python3.12/site-packages (from jinja2->torch>=1.11.0->sentence-transformers) (2.1.3)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in /opt/anaconda3/lib/python3.12/site-packages (from requests->huggingface-hub>=0.20.0->sentence-transformers) (3.3.2)\n",
      "Requirement already satisfied: idna<4,>=2.5 in /opt/anaconda3/lib/python3.12/site-packages (from requests->huggingface-hub>=0.20.0->sentence-transformers) (3.7)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in /opt/anaconda3/lib/python3.12/site-packages (from requests->huggingface-hub>=0.20.0->sentence-transformers) (2.2.3)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in /opt/anaconda3/lib/python3.12/site-packages (from requests->huggingface-hub>=0.20.0->sentence-transformers) (2024.8.30)\n"
     ]
    }
   ],
   "source": [
    "!pip install sentence-transformers\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "ebb80139",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ğŸ“ Found 74 fields to summarize:\n",
      "  â€¢ Protocol Summary - Master Disclosure Document for Interventional Studies\n",
      "  â€¢ The Information on this page will not be posted\n",
      "  â€¢ Before using this template for authoring, refer to the supplemental instructions on Find-IT. This template is used for ALL Interventional studies that evaluate the safety, efficacy or effectiveness of a GSK product.\n",
      "Master Disclosure Document (MDD) serves as the source document to disclose protocol related information across different clinical trial registers (e.g. ClinicalTrials.gov, EU Clinical Trials Information System (EU CTIS) and/or GSK/ViiV Clinical Study Register) as required by external regulations and/or GSK policy. Check in TMF for the latest version of the template before initiating a new MDD. As information from the approved MDD will be disclosed on publicly available clinical trial register(s) as required by applicable regulations and GSK policy, minimize inclusion of information that may be considered commercially confidential.\n",
      "  â€¢ Title of study\n",
      "  â€¢ Study identifier /CTMS number\n",
      "  â€¢ European Union (EU) Clinical Trial Regulation (EU CTR) number (if applicable)\n",
      "  â€¢ Is this an Applicable Clinical Trial (ACT)?\n",
      "  â€¢ Trial registers where the study will be disclosed\n",
      "  â€¢ MDD version date\n",
      "  â€¢ Approver:\n",
      "  â€¢ Clinical Lead/equivalent\n",
      "  â€¢ Section # and Name of the field\n",
      "{Add section number and name}\n",
      "  â€¢ Unique Protocol ID\n",
      "  â€¢ Brief title\n",
      "  â€¢ Acronym\n",
      "  â€¢ CTMS abbreviated title [EU only]\n",
      "  â€¢ Official title of the trial\n",
      "  â€¢ Secondary IDs\n",
      "  â€¢ Secondary ID type\n",
      "  â€¢ Sponsor\n",
      "  â€¢ Collaborators\n",
      "  â€¢ Brief summary\n",
      "  â€¢ Detailed description\n",
      "  â€¢ Main objective(s) [EU only]\n",
      "  â€¢ Secondary objective(s) [EU only]\n",
      "  â€¢ Data monitoring committee\n",
      "  â€¢ Keywords\n",
      "  â€¢ Medical condition(s) investigated [EU only]\n",
      "  â€¢ Therapeutic area [EU only]\n",
      "  â€¢ Rare disease [EU only]\n",
      "  â€¢ Primary purpose\n",
      "  â€¢ Study Phase\n",
      "  â€¢ Type of human pharmacology (Phase 1) study (EU only)\n",
      "  â€¢ Interventional study model\n",
      "  â€¢ Allocation\n",
      "  â€¢ Anticipated date of results (EU only)\n",
      "  â€¢ Number of arms\n",
      "  â€¢ Masking type \n",
      "(EU only)\n",
      "  â€¢ Masking description / Blinding implementation details\n",
      "  â€¢ Arms\n",
      "Repeat below rows depending on number of arms\n",
      "  â€¢ Arm / Group Label\n",
      "  â€¢ Arm / Group description\n",
      "  â€¢ Interventions\n",
      "Repeat below rows depending on number of interventions\n",
      "  â€¢ Intervention name\n",
      "  â€¢ Intervention description\n",
      "  â€¢ Other names\n",
      "  â€¢ Relationship between Arms & Interventions\n",
      "Repeat below rows depending on number of arms)\n",
      "  â€¢ Arm\n",
      "  â€¢ Outcome measure type\n",
      "  â€¢ Outcome measure title\n",
      "  â€¢ Outcome measure description\n",
      "  â€¢ Time frame\n",
      "  â€¢ Sex\n",
      "  â€¢ Gender based\n",
      "  â€¢ Age Limits\n",
      "  â€¢ Age ranges (EU only)\n",
      "  â€¢ Accepts healthy volunteers\n",
      "  â€¢ Study population types (EU only)\n",
      "  â€¢ Inclusion criteria\n",
      "  â€¢ Exclusion criteria\n",
      "  â€¢ Study Termination / Cancellation\n",
      "  â€¢ Recruitment status\n",
      "  â€¢ Why study stopped\n",
      "  â€¢ Investigational New Drug Application (IND)/Investigational Device Exemption (IDE) Information\n",
      "  â€¢ U.S. FDA IND/IDE study\n",
      "  â€¢ FDA center (formerly IND/IDE grantor)\n",
      "  â€¢ IND/IDE number\n",
      "  â€¢ IND serial number\n",
      "  â€¢ US FDA regulated drug\n",
      "  â€¢ Product exported from US\n",
      "  â€¢ Availability of expanded access\n",
      "  â€¢ Expanded access record National Clinical Trial (NCT) number\n",
      "  â€¢ Plan to share IPD data\n",
      "  â€¢ url\n"
     ]
    }
   ],
   "source": [
    "from docx import Document\n",
    "\n",
    "# Load the summary template\n",
    "summary_doc = Document(\"Summary.docx\")\n",
    "\n",
    "# Dynamically pull every field name from the first column of each table\n",
    "report_fields = []\n",
    "for table in summary_doc.tables:\n",
    "    for row in table.rows:\n",
    "        fld = row.cells[0].text.strip()\n",
    "        # skip empty rows, duplicates, or header placeholders\n",
    "        if fld and fld not in report_fields and fld.lower() not in (\"\", \"choose an item.\", \"click here to enter text\"):\n",
    "            report_fields.append(fld)\n",
    "\n",
    "print(f\"ğŸ“ Found {len(report_fields)} fields to summarize:\")\n",
    "for f in report_fields:\n",
    "    print(\"  â€¢\", f)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "4afa05e6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total source paragraphs: 835\n"
     ]
    }
   ],
   "source": [
    "# Assuming you saved paragraphs list from Day 1\n",
    "# If not, reload Protocol.docx again\n",
    "source_doc = Document(\"Protocol.docx\")\n",
    "paragraphs = [p.text.strip() for p in source_doc.paragraphs if p.text.strip()]\n",
    "\n",
    "print(f\"Total source paragraphs: {len(paragraphs)}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "54c4de9a",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sentence_transformers import SentenceTransformer, util\n",
    "\n",
    "# Load a pre-trained model that turns text into embeddings\n",
    "model = SentenceTransformer('all-MiniLM-L6-v2')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1db07d7f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Encode all source paragraphs into embeddings\n",
    "paragraph_embeddings = model.encode(paragraphs, convert_to_tensor=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "d2b6800f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "ğŸŸ© FIELD: Protocol Summary - Master Disclosure Document for Interventional Studies\n",
      "ğŸ” Best Matching Paragraph:\n",
      "6.\tSTUDY INTERVENTION(S) AND CONCOMITANT THERAPY\t46\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: The Information on this page will not be posted\n",
      "ğŸ” Best Matching Paragraph:\n",
      "PAGE\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Before using this template for authoring, refer to the supplemental instructions on Find-IT. This template is used for ALL Interventional studies that evaluate the safety, efficacy or effectiveness of a GSK product.\n",
      "Master Disclosure Document (MDD) serves as the source document to disclose protocol related information across different clinical trial registers (e.g. ClinicalTrials.gov, EU Clinical Trials Information System (EU CTIS) and/or GSK/ViiV Clinical Study Register) as required by external regulations and/or GSK policy. Check in TMF for the latest version of the template before initiating a new MDD. As information from the approved MDD will be disclosed on publicly available clinical trial register(s) as required by applicable regulations and GSK policy, minimize inclusion of information that may be considered commercially confidential.\n",
      "ğŸ” Best Matching Paragraph:\n",
      "The key design elements of this protocol and results summaries will be posted on www.ClinicalTrials.gov and/or GSK Clinical Study Register in compliance with applicable regulations/GSK policy. GSK will aim to register protocols summaries prior to study start and target results summaries submission within 12 months of primary/ study completion date. Where external regulations require earlier disclosure, GSK will follow those timelines.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Title of study\n",
      "ğŸ” Best Matching Paragraph:\n",
      "STUDY DESIGN\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Study identifier /CTMS number\n",
      "ğŸ” Best Matching Paragraph:\n",
      "STUDY DESIGN\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: European Union (EU) Clinical Trial Regulation (EU CTR) number (if applicable)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Providing oversight of the conduct of the study at the site and adherence to requirements of 21 Code of Federal Regulation (CFR), ICH guidelines, the IRB/IEC, European regulation 536/2014 for clinical studies (if applicable), and all other applicable local regulations\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Is this an Applicable Clinical Trial (ACT)?\n",
      "ğŸ” Best Matching Paragraph:\n",
      "The participant has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 3 months, 5 half-lives or twice the duration of the biological effect of the investigational product (whichever is longer).\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Trial registers where the study will be disclosed\n",
      "ğŸ” Best Matching Paragraph:\n",
      "STUDY ASSESSMENTS AND PROCEDURES\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: MDD version date\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Dates of administration including start and end dates\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Approver:\n",
      "ğŸ” Best Matching Paragraph:\n",
      "10.1.3.\tInformed consent process\t69\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Clinical Lead/equivalent\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Participant safety will be continuously monitored by the Sponsorâ€™s Medical Monitor, and designated Safety Lead (or delegate) throughout the study. Pertinent findings and conclusions are shared with the productâ€™s safety review team for review of the overall benefit-risk profile of the product.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Section # and Name of the field\n",
      "{Add section number and name}\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Medical Monitor Name and Contact Information:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Unique Protocol ID\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Protocol Title:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Brief title\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Brief Title:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Acronym\n",
      "ğŸ” Best Matching Paragraph:\n",
      "LIST OF ABBREVIATIONS AND DEFINITIONS OF TERMS\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: CTMS abbreviated title [EU only]\n",
      "ğŸ” Best Matching Paragraph:\n",
      "LIST OF ABBREVIATIONS AND DEFINITIONS OF TERMS\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Official title of the trial\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Brief Title:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Secondary IDs\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Secondary estimands\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Secondary ID type\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Secondary estimands\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Sponsor\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Sponsor Signatory:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Collaborators\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Activity\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Brief summary\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Brief Title:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Detailed description\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Synopsis\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Main objective(s) [EU only]\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Objectives, Endpoints, and Estimands:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Secondary objective(s) [EU only]\n",
      "ğŸ” Best Matching Paragraph:\n",
      "OBJECTIVES, ENDPOINTS AND ESTIMANDS\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Data monitoring committee\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Data Monitoring/Other Committee:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Keywords\n",
      "ğŸ” Best Matching Paragraph:\n",
      "REFERENCES\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Medical condition(s) investigated [EU only]\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Abnormal laboratory findings associated with the underlying disease are not considered clinically significant unless judged by the Investigator to be more severe than expected for the participantâ€™s condition.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Therapeutic area [EU only]\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Providing oversight of the conduct of the study at the site and adherence to requirements of 21 Code of Federal Regulation (CFR), ICH guidelines, the IRB/IEC, European regulation 536/2014 for clinical studies (if applicable), and all other applicable local regulations\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Rare disease [EU only]\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Abnormal laboratory findings associated with the underlying disease are not considered clinically significant unless judged by the Investigator to be more severe than expected for the participantâ€™s condition.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Primary purpose\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Reason for use\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Study Phase\n",
      "ğŸ” Best Matching Paragraph:\n",
      "STUDY DESIGN\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Type of human pharmacology (Phase 1) study (EU only)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Pharmacodynamics\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Interventional study model\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Study intervention(s) administered\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Allocation\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Committees structure\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Anticipated date of results (EU only)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Table 6\tTimeframes for submitting SAE, pregnancy and other events reports to GSK\t63\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Number of arms\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Number of Participants:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Masking type \n",
      "(EU only)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Blinding/Masking\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Masking description / Blinding implementation details\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Blinding/Masking\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Arms\n",
      "Repeat below rows depending on number of arms\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Exclusion criteria\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Arm / Group Label\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Not applicable as this is an open-label study.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Arm / Group description\n",
      "ğŸ” Best Matching Paragraph:\n",
      "The estimand is described by the following attributes:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Interventions\n",
      "Repeat below rows depending on number of interventions\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Table 4\tStudy intervention administered.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Intervention name\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Study intervention(s) administered\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Intervention description\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Assignment to study intervention\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Other names\n",
      "ğŸ” Best Matching Paragraph:\n",
      "REFERENCES\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Relationship between Arms & Interventions\n",
      "Repeat below rows depending on number of arms)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Table 4\tStudy intervention administered.\t48\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Arm\n",
      "ğŸ” Best Matching Paragraph:\n",
      "APPENDIX\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Outcome measure type\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Assessment of outcomes\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Outcome measure title\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Assessment of outcomes\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Outcome measure description\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Assessment of outcomes\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Time frame\n",
      "ğŸ” Best Matching Paragraph:\n",
      "* Timeframe allowed after receipt or awareness of the information by the Investigator/site staff.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Sex\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Activity\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Gender based\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Women in the following categories are considered WONCBP:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Age Limits\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Male or female 18 to 65 years, at the time of signing the informed consent form.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Age ranges (EU only)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Male or female 18 to 65 years, at the time of signing the informed consent form.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Accepts healthy volunteers\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Not applicable as this is a healthy volunteer study.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Study population types (EU only)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "STUDY POPULATION\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Inclusion criteria\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Inclusion criteria\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Exclusion criteria\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Exclusion criteria\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Study Termination / Cancellation\n",
      "ğŸ” Best Matching Paragraph:\n",
      "For study termination:\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Recruitment status\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Recruitment strategy\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Why study stopped\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Discontinuation of study intervention\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Investigational New Drug Application (IND)/Investigational Device Exemption (IDE) Information\n",
      "ğŸ” Best Matching Paragraph:\n",
      "The Investigator is obligated to perform or arrange for the conduct of supplemental measurements and/or evaluations as medically indicated or as requested by Sponsor to elucidate the nature and/or causality of the AE or SAE as fully as possible. This may include additional laboratory tests or investigations, histopathological examinations, or consultation with other health care professionals.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: U.S. FDA IND/IDE study\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Appendix 1: Regulatory, ethical, and study oversight considerations\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: FDA center (formerly IND/IDE grantor)\n",
      "ğŸ” Best Matching Paragraph:\n",
      "That I am aware of and will comply with Good Clinical Practise (GCP) and all applicable regulatory requirements.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: IND/IDE number\n",
      "ğŸ” Best Matching Paragraph:\n",
      "An Investigator who receives an Investigator safety report describing an SAE or other specific safety information (e.g., summary or listing of SAEs) from the Sponsor will review and then file it along with the (IB/ investigational directions for use [IDFU]/package insert or state other documents) and will notify the IRB/IEC, if appropriate according to local requirements.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: IND serial number\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Participants will be allocated a unique enrolment number at the study site. This number will be retained regardless of whether the participant subsequently fulfils the eligibility criteria. If a participant withdraws from the study, the enrolment number will not be reused, and the participant will not be allowed to re-enter the study.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: US FDA regulated drug\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Regulatory and ethical considerations\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Product exported from US\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Seroxat [SmPC; Summary of Product Characteristics].Â Brentford, UK:Â GSK; 2022.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Availability of expanded access\n",
      "ğŸ” Best Matching Paragraph:\n",
      "Inclusion criteria\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Expanded access record National Clinical Trial (NCT) number\n",
      "ğŸ” Best Matching Paragraph:\n",
      "10.1.7.\tDissemination of Clinical Study Data\t71\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: Plan to share IPD data\n",
      "ğŸ” Best Matching Paragraph:\n",
      "The participant must be informed that their personal study-related data will be used by the Sponsor in accordance with local data protection law. The level of disclosure must also be explained to the participant, that their data will be used as described in the informed consent.\n",
      "\n",
      "\n",
      "ğŸŸ© FIELD: url\n",
      "ğŸ” Best Matching Paragraph:\n",
      "PAGE\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Dictionary to store best-matched paragraph for each field\n",
    "matched_paragraphs = {}\n",
    "\n",
    "for field in report_fields:\n",
    "    # Encode the field name\n",
    "    field_embedding = model.encode(field, convert_to_tensor=True)\n",
    "\n",
    "    # Calculate cosine similarity with all source paragraphs\n",
    "    similarities = util.cos_sim(field_embedding, paragraph_embeddings)[0]\n",
    "\n",
    "    # Find the index of the paragraph with the highest similarity score\n",
    "    top_idx = similarities.argmax()\n",
    "    best_para = paragraphs[top_idx]\n",
    "\n",
    "    print(f\"\\nğŸŸ© FIELD: {field}\")\n",
    "    print(f\"ğŸ” Best Matching Paragraph:\\n{best_para}\\n\")\n",
    "\n",
    "    # Save the match\n",
    "    matched_paragraphs[field] = best_para\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "c0e9f4e0",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "\n",
    "# Save the matched paragraphs from Day 2 into a file\n",
    "with open(\"matched_paragraphs.json\", \"w\") as f:\n",
    "    json.dump(matched_paragraphs, f, indent=2)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
